Last CNY11.99 CNY
Change Today +0.36 / 3.10%
Volume 4.9M
As of 3:00 AM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

baotou dongbao bio-tech co-a (300239) Snapshot

Open
CNY11.60
Previous Close
CNY11.63
Day High
CNY11.99
Day Low
CNY11.55
52 Week High
10/21/13 - CNY14.12
52 Week Low
05/9/14 - CNY9.25
Market Cap
2.4B
Average Volume 10 Days
5.0M
EPS TTM
CNY0.22
Shares Outstanding
197.5M
EX-Date
06/12/14
P/E TM
54.5x
Dividend
CNY0.08
Dividend Yield
0.67%
Current Stock Chart for BAOTOU DONGBAO BIO-TECH CO-A (300239)

Related News

No related news articles were found.

baotou dongbao bio-tech co-a (300239) Related Businessweek News

No Related Businessweek News Found

baotou dongbao bio-tech co-a (300239) Details

Baotou Dongbao Bio-Tech Co., Ltd. engages in the research, development, manufacture, and distribution of gelatin series products and low molecular mass collagen in China and internationally. The company provides photographic gelatin; pharmaceutical gelatin for use in the manufacture of soft and hard capsules, medicines, suppositories, plasma substitutes, sugar-coated tablets, surgical powders, gelatin dressings, gelatin sponges, cosmetics, health products, and others; and edible gelatin for use in candies, desserts, cold drinks, jellies, skin cold, drinks, sausages, canned foods, wines, juice clarification, meat products, dairy processing, and catering and other food industries. It also offers collagen for use in food, cosmetics, functional health products, and other fields; and DCP for use in feed, animal husbandry, and other related industries. Baotou Dongbao Bio-Tech Co., Ltd. was founded in 1997 and is based in Baotou, China.

Founded in 1997

baotou dongbao bio-tech co-a (300239) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

baotou dongbao bio-tech co-a (300239) Key Developments

Baotou Dongbao Bio-Tech Co.,Ltd Approves Amendments to Articles of Association

Baotou Dongbao Bio-Tech Co.,Ltd held its second extraordinary general meeting of 2014 on 26 August 2014. During the meeting, shareholders of the company approved amendments to the company's articles of association.

Baotou Dongbao Bio-Tech Co.,Ltd Proposes Amendments to the Articles of Association

Baotou Dongbao Bio-Tech Co.,Ltd proposed amendments to the company's articles of association, at the extraordinary general meeting to be held on August 26, 2014.

Baotou Dongbao Bio-Tech Co.,Ltd, Special/Extraordinary Shareholders Meeting, Aug 26, 2014

Baotou Dongbao Bio-Tech Co.,Ltd, Special/Extraordinary Shareholders Meeting, Aug 26, 2014., at 10:00 China Standard Time. Agenda: To consider the eligibility for non-public share offering; to consider scheme for non-public share offering; to consider preplan for non-public share offering; to consider demonstration analysis report on scheme for non-public share offering; to consider report on use of previously raised funds; to consider feasibility report on use of proceeds from the non-public share offering; to consider authorization to the board to handle matters in relation to non-public share offering; to consider amendments to the company's articles of association; to consider amendments to the company's rules of procedures governing shareholders' general meetings; and to consider the plan for the shareholders profit return for the next three years 2014-2016.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300239:CH CNY11.99 CNY +0.36

300239 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300239.
View Industry Companies
 

Industry Analysis

300239

Industry Average

Valuation 300239 Industry Range
Price/Earnings 100.0x
Price/Sales 8.1x
Price/Book 6.8x
Price/Cash Flow 105.0x
TEV/Sales 7.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAOTOU DONGBAO BIO-TECH CO-A, please visit www.dongbaoshengwu.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.